Back
Results - Announcements
IOL Chemicals & Pharmaceuticals Ltd consolidated sales up 22.09% on year in Q2FY2026, net profit surged by 21.14%
10-Aug-2026, 04:44
IOL Chemicals & Pharmaceuticals Ltd share price gained 2.85% to Rs 167.8 after the company's net profit jumped 21.14% to Rs 64.4 crore, while revenue from operations increased sharply by 22.09% to Rs 756.26 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 24.54 lakh crore, gaining 5.24%. It has marginally improved by 0.74% over last one week and heading higher by 13.39% in last one month while the market capitalization of IOL Chemicals & Pharmaceuticals Ltd has edged up by 10.65% and 58.74% in the same period respectively. Profit before tax (PBT) of IOL Chemicals & Pharmaceuticals Ltd stood at Rs 86.69 crore in Q2 FY26, rallying 90.49% year-on-year, and surging by 22.43% quarter-on-quarter. EBITDA came in at Rs 95 crore, expanding by 74.02% YoY and easing 5.16% sequentially. Total expenses jumped by 23.18% to Rs 674.11 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 506.76 crore, jumping 26.17% YoY, while employee benefits expense was at Rs 71.21 crore, ticking higher by 1.25% YoY. For the TTM ended FY26, revenue from operations softened by 2.51% to Rs 2079.21 crore, while net profit tanked by 24.82% to Rs 101.07 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 20860% to Rs 179.89 crore, and PBT plunged by 24.05% to Rs 137.96 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 178.62 crore in FY26, as against Rs 290.08 crore in FY25. IOL Chemicals & Pharmaceuticals Ltd soared by 71.22% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 2.63% during the same period.
IOL Chemicals & Pharmaceuticals Ltd share price gained 2.85% to Rs 167.8 after the company's net profit jumped 21.14% to Rs 64.4 crore, while revenue from operations increased sharply by 22.09% to Rs 756.26 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 24.54 lakh crore, gaining 5.24%. It has marginally improved by 0.74% over last one week and heading higher by 13.39% in last one month while the market capitalization of IOL Chemicals & Pharmaceuticals Ltd has edged up by 10.65% and 58.74% in the same period respectively. Profit before tax (PBT) of IOL Chemicals & Pharmaceuticals Ltd stood at Rs 86.69 crore in Q2 FY26, rallying 90.49% year-on-year, and surging by 22.43% quarter-on-quarter. EBITDA came in at Rs 95 crore, expanding by 74.02% YoY and easing 5.16% sequentially. Total expenses jumped by 23.18% to Rs 674.11 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 506.76 crore, jumping 26.17% YoY, while employee benefits expense was at Rs 71.21 crore, ticking higher by 1.25% YoY. For the TTM ended FY26, revenue from operations softened by 2.51% to Rs 2079.21 crore, while net profit tanked by 24.82% to Rs 101.07 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 20860% to Rs 179.89 crore, and PBT plunged by 24.05% to Rs 137.96 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 178.62 crore in FY26, as against Rs 290.08 crore in FY25. IOL Chemicals & Pharmaceuticals Ltd soared by 71.22% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 2.63% during the same period.